Literature DB >> 27493386

Patent ductus arteriosus in preterm infant: Basic pathology and when to treat.

Abdulrahman M H Al Nemri1.   

Abstract

The incidence of patent ductus arteriosus (PDA) in premature neonates varies according to the gestational age and respiratory status. Failure of PDA closure in preterm infants with respiratory distress syndrome results in a left to right shunt across the duct which may lead to pulmonary congestion and deterioration in respiratory status. Although indomethacin and ibuprofen are the main stay of medical treatment, conservative approach by restricted fluid and applying continuous positive airway pressure (CPAP) may be effective in prevention of PDA without complication. The daily clinical round debate on how to diagnose, when, and how to treat PDA in preterm neonates will be discussed with details in this review.

Entities:  

Keywords:  Ibuprofen; Indomethacin; Patent ductus arteriosus; Preterm infant; Surgical closure

Year:  2014        PMID: 27493386      PMCID: PMC4949912     

Source DB:  PubMed          Journal:  Sudan J Paediatr        ISSN: 0256-4408


  20 in total

1.  Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less.

Authors:  Josh Koch; Gaynelle Hensley; Lonnie Roy; Shannon Brown; Claudio Ramaciotti; Charles R Rosenfeld
Journal:  Pediatrics       Date:  2006-04       Impact factor: 7.124

Review 2.  Patent ductus arteriosus.

Authors:  Douglas J Schneider; John W Moore
Journal:  Circulation       Date:  2006-10-24       Impact factor: 29.690

3.  Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP).

Authors:  Barbara Schmidt; Robin S Roberts; Avroy Fanaroff; Peter Davis; Haresh M Kirpalani; Chuks Nwaesei; Michael Vincer
Journal:  J Pediatr       Date:  2006-06       Impact factor: 4.406

4.  Precision and accuracy of clinical and radiological signs in premature infants at risk of patent ductus arteriosus.

Authors:  P Davis; S Turner-Gomes; K Cunningham; C Way; R Roberts; B Schmidt
Journal:  Arch Pediatr Adolesc Med       Date:  1995-10

5.  Randomized pilot study comparing oral ibuprofen with intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus.

Authors:  Ahmed Cherif; Naima Khrouf; Sami Jabnoun; Chahnez Mokrani; Moez Ben Amara; Nedia Guellouze; Samia Kacem
Journal:  Pediatrics       Date:  2008-12       Impact factor: 7.124

6.  The Vermont-Oxford Trials Network: very low birth weight outcomes for 1990. Investigators of the Vermont-Oxford Trials Network Database Project.

Authors: 
Journal:  Pediatrics       Date:  1993-03       Impact factor: 7.124

7.  Failure of ductus arteriosus closure is associated with increased mortality in preterm infants.

Authors:  Shahab Noori; Michael McCoy; Philippe Friedlich; Brianna Bright; Venugopal Gottipati; Istvan Seri; Kris Sekar
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

8.  Prevention and 18-month outcomes of serious pulmonary hemorrhage in extremely low birth weight infants: results from the trial of indomethacin prophylaxis in preterms.

Authors:  Khalid Alfaleh; John A Smyth; Robin S Roberts; Alfonso Solimano; Elizabeth V Asztalos; Barbara Schmidt
Journal:  Pediatrics       Date:  2008-02       Impact factor: 7.124

Review 9.  Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.

Authors:  A Ohlsson; R Walia; S Shah
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

Review 10.  Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.

Authors:  C Herrera; J Holberton; P Davis
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18
View more
  2 in total

1.  Brain and renal oxygenation measured by NIRS related to patent ductus arteriosus in preterm infants: a prospective observational study.

Authors:  Jurate Navikiene; Ernestas Virsilas; Ramune Vankeviciene; Arunas Liubsys; Augustina Jankauskiene
Journal:  BMC Pediatr       Date:  2021-12-09       Impact factor: 2.125

2.  Persistent Ductus Arteriosus in Critically Ill Preterm Infants.

Authors:  Maria Livia Ognean; Oana Boantă; Simona Kovacs; Corina Zgârcea; Raluca Dumitra; Ecaterina Olariu; Doina Andreicuţ
Journal:  J Crit Care Med (Targu Mures)       Date:  2016-11-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.